Lee's Pharmaceutical (HKG:0950) said it secured U.S. regulatory approval to move commercial manufacturing of its Adasuve drug from Mountain View, California, to Fremont, California, according to a Hong Kong bourse filing Tuesday.
The firm's shares were up nearly 6% in late morning trade Wednesday.
Adasuve, also known as loxapine, was acquired by the company in December.